Jordan Scott 4
4 · Salarius Pharmaceuticals, Inc. · Filed Feb 18, 2020
Insider Transaction Report
Form 4
Jordan Scott
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-02-18$0.90/sh+11,300$10,170→ 31,609 total
Footnotes (1)
- [F1]Includes 2,538 shares of unvested Common Stock which will become fully vested on June 30, 2020.